• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Quest Diagnostics Inc.

Stryker CEO Kevin Lobo shares successful strategies for managing multiple crises (aka life in 2020)

December 11, 2020 By Tom Salemi

The past 12 months of pandemic, social unrest and a divisive election – provided a crash course in crisis management for CEOs. In this week’s DeviceTalks Weekly Podcast, Kevin Lobo, the CEO of Stryker, explains how he led his company through this this difficult year. His recipe for success is long, but it includes priorities, […]

Filed Under: Featured, Orthopedics, Robotics Tagged With: Boston Scientific, Medtronic, Quest Diagnostics Inc., Stryker

The top 5 MassDevice stories of the week — December 11, 2020

December 11, 2020 By Sean Whooley

The medtech industry continues to plug along as major news comes in about vaccines, the incoming presidential administration and more. This week’s top stories include the latest on COVID-19, Joe Biden and some additional FDA clearances, plus a major royalties spat. Want to hear more about the week’s top medtech news on MassDevice? Tom Salemi will […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Legal News, Neurological, Neuromodulation/Neurostimulation, Pharmaceutical, Regulatory/Compliance Tagged With: BioNTech, Boston Scientific, Centers for Disease Control & Prevention (CDC), coronavirus, COVID-19, Dept. of Health & Human Services (HHS), FDA, Joe Biden, Medtronic, Pfizer, Quest Diagnostics Inc.

FDA authorizes at-home COVID+flu test from Quest Diagnostics

December 7, 2020 By Sean Whooley

The FDA has given emergency use authorization for a COVID-19 and flu combination diagnostic from  Quest Diagnostics (NYSE:DGX). In a letter to San Juan Capistrano, Calif.-based Quest Diagnostics, the FDA said that, while it has approved tests for influenza A and influenza B, there are no FDA-approved multiplexed tests for flu/SARS-CoV-2 combination testing. Additionally, no self-collected, […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Quest Diagnostics Inc.

MedTech 100 roundup: Stagnant week for industry

September 21, 2020 By Sean Whooley

Medtech stocks made a run at a new peak over the past week, but ultimately remained mostly unchanged from the previous seven days. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 89.3 (Sep. 18), marking a 0.3% gain from the 89.03 points registered at […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: coronavirus, COVID-19, Hologic, Intersect ENT, MedTech 100 Index, Outset Medical, Quest Diagnostics Inc.

Quest lets consumers order COVID-19 tests online

September 17, 2020 By Nancy Crotti

Quest Diagnostics (NYSE:DGX) today announced that consumers will be able to order one of its COVID-19 diagnostics online and collect the specimen at home, without visiting a doctor’s office. QuestDirect Active Infection is also available by drive-through at more than 500 Walmart Neighborhood Market locations. Results are interpreted by a physician and provided digitally through the […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Distribution, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Quest Diagnostics Inc.

Hologic applies for pooled COVID-19 testing nod

August 11, 2020 By Nancy Crotti

Hologic (NSDQ:HOLX) announced today that it has self-validated use of its Aptima and Panther Fusion molecular diagnostic COVID-19 assays with pooled patient samples and applied for an FDA emergency use authorization (EUA) for pooled testing. Marlborough, Mass.-based Hologic is the third major company to announce it is seeking such authorization. Quest Diagnostics (NYSE:DGX) gained a pooled-sample testing […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance, Research & Development, Wall Street Beat Tagged With: coronavirus, COVID-19, FDA, Hologic, LabCorp, Quest Diagnostics Inc.

New Quest lab method gains FDA nod

July 31, 2020 By Sean Whooley

Quest Diagnostics (NYSE:DGX) announced that it received FDA emergency use authorization (EUA) for a new laboratory technique for extracting viral RNA. Secaucus, N.J.-based Quest Diagnostics’ new technique is designed to speed up the process of extracting viral RNA from specimens in an effort to expand daily capacity of COVID-19 molecular diagnostic tests in the U.S., according […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Quest Diagnostics Inc.

LabCorp COVID-19 test may be used on asymptomatic people

July 27, 2020 By Nancy Crotti

The FDA on Friday added two new indications for the use of a Laboratory Corporation of America (NYSE:LH) COVID-19 RT-PCR diagnostic: to test people who have no symptoms of the virus or have no reason to believe they’ve been exposed; and to allow pooled testing of up to five samples from different people. The test, which received an emergency […]

Filed Under: Business/Financial News, Diagnostics, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, LabCorp, Quest Diagnostics Inc.

Quest COVID-19 test wins FDA nod for pooled sampling

July 20, 2020 By Nancy Crotti

The FDA has authorized a Quest Diagnostics (NYSE:DGX) test for COVID-19 to be used with pooled samples — the first such authorization by the agency since Dr. Anthony Fauci, the nation’s leading infectious disease specialist, started publicly discussing pooled-sample testing about three weeks ago. The authorization, announced Saturday, permits the pooled testing of up to four […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance, Wall Street Beat Tagged With: coronavirus, COVID-19, FDA, Quest Diagnostics Inc.

Quest lands FDA nod for at-home COVID-19 test

May 29, 2020 By Nancy Crotti

Quest Diagnostics (NYSE:DGX) has received an FDA emergency use authorization (EUA) for an at-home diagnostic test for COVID-19. The Secaucus, N.J.-based testing giant said the test kit is for individuals to self-collect a nasal specimen at home or in a healthcare setting when determined to be appropriate by a healthcare provider. It allows an individual to […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: COVID-19, Quest Diagnostics Inc.

Quest Diagnostics launches patient-ordered COVID-19 antibody test

April 28, 2020 By Nancy Crotti

Quest Diagnostics (NYSE:DGX) announced today that consumers can now order a COVID-19 antibody test it launched last week directly from the company, without visiting a doctor’s office. The Secaucus, N.J.-based testing giant said consumers can purchase the antibody test service online for $119 through its QuestDirect business. They will be prompted to schedule an appointment for […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, euroimmun, FDA, PerkinElmer Inc., PWN Health, Quest Diagnostics Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS